Literature DB >> 11266418

Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis.

Y Onodera1, M Tanaka, K Sato.   

Abstract

The in vitro inhibitory activities of quinolones against Mycobacterium tuberculosis DNA gyrase were measured. The 50% inhibitory concentrations (IC(50)s) of sitafloxacin (DU-6859a), sparfloxacin, ciprofloxacin and levofloxacin against supercoiling activity of DNA gyrase were 1.67, 4.80, 12.2 and 13.9 mg/L, respectively, and correlated well with their MICs. Two altered proteins of GyrA containing Ala-90Val, or Ala-90Val and Asp-94Gly were also purified and the inhibitory activities of the quinolones ranged from 12 to >83 times weaker than those against the wild-type enzyme. These results suggest that mutations in the corresponding genes confer quinolone resistance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11266418     DOI: 10.1093/jac/47.4.447

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  14 in total

1.  Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes.

Authors:  Alexandra Aubry; Nicolas Veziris; Emmanuelle Cambau; Chantal Truffot-Pernot; Vincent Jarlier; L Mark Fisher
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Optimization of pyrrolamides as mycobacterial GyrB ATPase inhibitors: structure-activity relationship and in vivo efficacy in a mouse model of tuberculosis.

Authors:  Shahul Hameed P; Suresh Solapure; Kakoli Mukherjee; Vrinda Nandi; David Waterson; Radha Shandil; Meenakshi Balganesh; Vasan K Sambandamurthy; Anand Kumar Raichurkar; Abhijeet Deshpande; Anirban Ghosh; Disha Awasthy; Gajanan Shanbhag; Gulebahar Sheikh; Helen McMiken; Jayashree Puttur; Jitendar Reddy; Jim Werngren; Jon Read; Mahesh Kumar; Manjunatha R; Murugan Chinnapattu; Prashanti Madhavapeddi; Praveena Manjrekar; Reetobrata Basu; Sheshagiri Gaonkar; Sreevalli Sharma; Sven Hoffner; Vaishali Humnabadkar; Venkita Subbulakshmi; Vijender Panduga
Journal:  Antimicrob Agents Chemother       Date:  2013-10-14       Impact factor: 5.191

Review 3.  Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis.

Authors:  Hanna Nebenzahl-Guimaraes; Karen R Jacobson; Maha R Farhat; Megan B Murray
Journal:  J Antimicrob Chemother       Date:  2013-09-20       Impact factor: 5.790

4.  Apicoplast-targeting antibacterials inhibit the growth of Babesia parasites.

Authors:  Mahmoud Aboulaila; Tserendorj Munkhjargal; Thillaiampalam Sivakumar; Akio Ueno; Yuki Nakano; Miki Yokoyama; Takeshi Yoshinari; Daisuke Nagano; Koji Katayama; Nasr El-Bahy; Naoaki Yokoyama; Ikuo Igarashi
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

5.  Characteristic resistance mechanism of Mycobacterium tuberculosis to DC-159a, a new respiratory quinolone.

Authors:  Jun-ichiro Sekiguchi; Areeya Disratthakit; Shinji Maeda; Norio Doi
Journal:  Antimicrob Agents Chemother       Date:  2011-05-09       Impact factor: 5.191

6.  Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.

Authors:  Areeya Disratthakit; Therdsak Prammananan; Chanwit Tribuddharat; Iyarit Thaipisuttikul; Norio Doi; Manoon Leechawengwongs; Angkana Chaiprasert
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

7.  Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity.

Authors:  Alexandra Aubry; Xiao-Su Pan; L Mark Fisher; Vincent Jarlier; Emmanuelle Cambau
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

8.  QSAR based predictive modeling for anti-malarial molecules.

Authors:  Deepak R Bharti; Andrew M Lynn
Journal:  Bioinformation       Date:  2017-05-31

9.  Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis.

Authors:  Regina Wilson; Pradeep Kumar; Vijay Parashar; Catherine Vilchèze; Romain Veyron-Churlet; Joel S Freundlich; S Whitney Barnes; John R Walker; Michael J Szymonifka; Emily Marchiano; Shubhada Shenai; Roberto Colangeli; William R Jacobs; Matthew B Neiditch; Laurent Kremer; David Alland
Journal:  Nat Chem Biol       Date:  2013-06-16       Impact factor: 15.040

Review 10.  Anti-malarial Drug Design by Targeting Apicoplasts: New Perspectives.

Authors:  Avinaba Mukherjee; Gobinda Chandra Sadhukhan
Journal:  J Pharmacopuncture       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.